A Phase I/II Study of VTX-801 in Adult Patients With Wilson's Disease
Condition: Wilson's Disease Intervention: Genetic: VTX-801 Sponsor: Vivet Therapeutics SAS Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 3, 2020 Category: Research Source Type: clinical trials